Bacterial translocation from the gastrointestinal tract in various mouse models for human diabetes

Microbiol Immunol. 1991;35(9):789-94. doi: 10.1111/j.1348-0421.1991.tb01611.x.

Abstract

Bacterial translocation from the gastrointestinal (GI) tract to other internal organs was examined in multiple low-dose streptozotocin-injected (M-STZ), single large-dose streptozotocin-injected (S-STZ), alloxan-injected (Alloxan), and non-obese diabetic (NOD) mice. The incidence of bacterial translocation from the GI tract to the tested organs among diabetic mice was in the order of M-STZ mice greater than S-STZ mice greater than NOD, Alloxan, and control mice. The injections of insulin to M-STZ mice did not decrease the incidence of translocation. These results suggest that bacterial translocation from the GI tract in diabetic mice is not induced by diabetes.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Blood / microbiology
  • Cecum / microbiology
  • Cell Movement*
  • Diabetes Mellitus, Experimental / complications
  • Diabetes Mellitus, Experimental / microbiology*
  • Digestive System / microbiology*
  • Escherichia coli Infections / complications*
  • Gastrointestinal Contents / microbiology*
  • Liver / microbiology
  • Lymph Nodes / microbiology
  • Male
  • Mice
  • Mice, Inbred ICR
  • Peritoneum / microbiology
  • Specific Pathogen-Free Organisms
  • Spleen / microbiology